Finance

Lists
500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹ 2,530.90
+0.31%
(+7.90) 1D
10-р сарын 16, 09:32:19 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500660...
Open
₹ 2,527.25
High
₹ 2,533.70
Low
₹ 2,527.25
Mkt. cap
429.65Т
Avg. vol.
5.03 мян
Volume
54.00
Dividend
2.25%
Quarterly dividend
₹ 14.25
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
40.14
52-wk high
₹ 3,121.10
52-wk low
₹ 2,088.00
EPS
₹ 63.05
Shares outstanding
169.41 сая
No. of employees
3 мян
Open
₹ 2,527.25
High
₹ 2,533.70
Low
₹ 2,527.25
Mkt. cap
429.65Т
Avg. vol.
5.03 мян
Volume
54.00
Dividend
2.25%
Quarterly dividend
₹ 14.25
Ex-dividend date
2026 оны 5-р сарын 29
P/E ratio
40.14
52-wk high
₹ 3,121.10
52-wk low
₹ 2,088.00
EPS
₹ 63.05
Shares outstanding
169.41 сая
No. of employees
3 мян
News stories
From web sources and news partners
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1 мян
Founded1924 оны 11-р сарын 13
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 3
Fiscal period
Q1 2027
₹ 14.00 / ₹ 13.90
+0.72%beat
Revenue / Est. (INR)
9.38 тэрбум / 9.11 тэрбум
+3.00%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
9.80 тэрбум
10.41 тэрбум
9.95 тэрбум
9.38 тэрбум
Cost of goods sold
3.56 тэрбум
3.64 тэрбум
3.69 тэрбум
3.28 тэрбум
Cost of revenue
3.56 тэрбум
3.64 тэрбум
3.69 тэрбум
3.28 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.38 тэрбум
1.52 тэрбум
2.95 тэрбум
1.59 тэрбум
Operating expense
3.06 тэрбум
3.26 тэрбум
2.84 тэрбум
3.31 тэрбум
Total operating expenses
6.62 тэрбум
6.90 тэрбум
6.53 тэрбум
6.59 тэрбум
Operating income
3.18 тэрбум
3.51 тэрбум
3.43 тэрбум
2.80 тэрбум
Other non operating income
335.70 сая
321.20 сая
-1.09 тэрбум
437.60 сая
EBT including unusual items
3.54 тэрбум
4.00 тэрбум
3.73 тэрбум
3.22 тэрбум
EBT excluding unusual items
3.51 тэрбум
3.82 тэрбум
2.94 тэрбум
3.22 тэрбум
Income tax expense
965.10 сая
1.04 тэрбум
952.41 сая
852.70 сая
Effective tax rate
27.26%
26.08%
25.53%
26.44%
Other operating expenses
1.51 тэрбум
1.54 тэрбум
-236.82 сая
1.56 тэрбум
Net income
2.57 тэрбум
2.96 тэрбум
2.78 тэрбум
2.37 тэрбум
Net profit margin
26.28%
28.39%
27.92%
25.27%
Earnings per share
-
-
-
14.00
Interest and investment income
-
-
657.30 сая
-
Interest expense
-5.10 сая
-11.90 сая
-6.12 сая
-9.70 сая
Net interest expenses
-5.10 сая
-11.90 сая
651.18 сая
-9.70 сая
Depreciation and amortization charges
174.30 сая
203.20 сая
131.74 сая
158.40 сая
EBITDA
3.35 тэрбум
3.61 тэрбум
3.52 тэрбум
2.89 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс